The COVID-19 pandemic has made consumers more aware of pathogens than ever before. For investors looking to take advantage of this increased awareness, consider FendX Technologies comes into play.
FendX is a nanotechnology company focused on developing products that reduce the spread of pathogens. The company listed on the CSE just this Monday (March 20th) under the ticker FNDX.c. Since Monday FNDX shares are already up 26.7% with the company seeing 24.6% gains today.
FNDX's primary offering is RepelWrap, a parent-pending and first-of-its-kind coating that uses proprietary technology to repel viruses and bacteria upon touch. Repel is the keyword here as other products attempt to kill pathogens, but RepelWrap is the only one that can repel them.
FNDX is on track to commercialize and launch RepelWrap Film Coating in Canada in 2024.
RepelWrap has numerous potential applications in healthcare and beyond. Once RepelWrap Film launches FNDX plans to create a RepelWrap extension line which will include catheter coatings and more.
Overall, the surface coating market is estimated to grow at an 18% CAGR to US$3.5 billion by 2025. FNDX is positioning itself to capture a significant market share.
For more information on FendX Technologies (FNDX.c) check out their website here: https://fendxtech.com/
Posted on behalf of FendX Technologies Inc